166 related articles for article (PubMed ID: 37326108)
1. Inhibition of protein arginine deiminase II suppresses retinoblastoma in orthotopic transplantation in mice.
Kim S; Song YK; Cho CS; Kim HJ; Fang S; Jo DH; Kim H
Oncol Rep; 2023 Jul; 50(1):. PubMed ID: 37326108
[TBL] [Abstract][Full Text] [Related]
2. Peptidyl arginine deiminase 2 (Padi2) is expressed in Sertoli cells in a specific manner and regulated by SOX9 during testicular development.
Tsuji-Hosokawa A; Kashimada K; Kato T; Ogawa Y; Nomura R; Takasawa K; Lavery R; Coschiera A; Schlessinger D; Harley VR; Takada S; Morio T
Sci Rep; 2018 Sep; 8(1):13263. PubMed ID: 30185873
[TBL] [Abstract][Full Text] [Related]
3. Treatment of RB-deficient retinoblastoma with Aurora-A kinase inhibitor.
Yang W; Jiang XX; Zhao XY; Mao PA
Kaohsiung J Med Sci; 2022 Mar; 38(3):244-252. PubMed ID: 34741392
[TBL] [Abstract][Full Text] [Related]
4. Protein-arginine deiminase 2 suppresses proliferation of colon cancer cells through protein citrullination.
Funayama R; Taniguchi H; Mizuma M; Fujishima F; Kobayashi M; Ohnuma S; Unno M; Nakayama K
Cancer Sci; 2017 Apr; 108(4):713-718. PubMed ID: 28403548
[TBL] [Abstract][Full Text] [Related]
5. Delayed puberty, gonadotropin abnormalities and subfertility in male Padi2/Padi4 double knockout mice.
Sams KL; Mukai C; Marks BA; Mittal C; Demeter EA; Nelissen S; Grenier JK; Tate AE; Ahmed F; Coonrod SA
Reprod Biol Endocrinol; 2022 Oct; 20(1):150. PubMed ID: 36224627
[TBL] [Abstract][Full Text] [Related]
6.
Ballasy NN; Bering EA; Kokorudz C; Radford BN; Zhao X; Dean W; Hemberger M
Cells; 2022 Aug; 11(16):. PubMed ID: 36010543
[TBL] [Abstract][Full Text] [Related]
7. Co-deleting Pten with Rb in retinal progenitor cells in mice results in fully penetrant bilateral retinoblastomas.
Xie C; Lu H; Nomura A; Hanse EA; Forster CL; Parker JB; Linden MA; Karasch C; Hallstrom TC
Mol Cancer; 2015 Apr; 14():93. PubMed ID: 25907958
[TBL] [Abstract][Full Text] [Related]
8. PADI2-Mediated Citrullination Promotes Prostate Cancer Progression.
Wang L; Song G; Zhang X; Feng T; Pan J; Chen W; Yang M; Bai X; Pang Y; Yu J; Han J; Han B
Cancer Res; 2017 Nov; 77(21):5755-5768. PubMed ID: 28819028
[TBL] [Abstract][Full Text] [Related]
9. Identification of PADI2 as a potential breast cancer biomarker and therapeutic target.
McElwee JL; Mohanan S; Griffith OL; Breuer HC; Anguish LJ; Cherrington BD; Palmer AM; Howe LR; Subramanian V; Causey CP; Thompson PR; Gray JW; Coonrod SA
BMC Cancer; 2012 Oct; 12():500. PubMed ID: 23110523
[TBL] [Abstract][Full Text] [Related]
10. UHRF1 downmodulation enhances antitumor effects of histone deacetylase inhibitors in retinoblastoma by augmenting oxidative stress-mediated apoptosis.
Kim JK; Kan G; Mao Y; Wu Z; Tan X; He H; Lee C
Mol Oncol; 2020 Feb; 14(2):329-346. PubMed ID: 31782885
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Targeting PLK1 by ON-01910.Na Is Effective in Local Treatment of Retinoblastoma.
Ma H; Nie C; Chen Y; Li J; Xie Y; Tang Z; Gao Y; Ai S; Mao Y; Sun Q; Lu R
Oncol Res; 2021 Sep; 28(7):745-761. PubMed ID: 33573708
[TBL] [Abstract][Full Text] [Related]
12. L1 increases adhesion-mediated proliferation and chemoresistance of retinoblastoma.
Jo DH; Lee K; Kim JH; Jun HO; Kim Y; Cho YL; Yu YS; Min JK; Kim JH
Oncotarget; 2017 Feb; 8(9):15441-15452. PubMed ID: 28061460
[TBL] [Abstract][Full Text] [Related]
13. Arginine Citrullination at the C-Terminal Domain Controls RNA Polymerase II Transcription.
Sharma P; Lioutas A; Fernandez-Fuentes N; Quilez J; Carbonell-Caballero J; Wright RHG; Di Vona C; Le Dily F; Schüller R; Eick D; Oliva B; Beato M
Mol Cell; 2019 Jan; 73(1):84-96.e7. PubMed ID: 30472187
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D analogs, a new treatment for retinoblastoma: The first Ellsworth Lecture.
Albert DM; Nickells RW; Gamm DM; Zimbric ML; Schlamp CL; Lindstrom MJ; Audo I
Ophthalmic Genet; 2002 Sep; 23(3):137-56. PubMed ID: 12324873
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy for retinoblastoma.
Chan HS; Gallie BL; Munier FL; Beck Popovic M
Ophthalmol Clin North Am; 2005 Mar; 18(1):55-63, viii. PubMed ID: 15763191
[TBL] [Abstract][Full Text] [Related]
16. Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma.
Van Quill KR; Dioguardi PK; Tong CT; Gilbert JA; Aaberg TM; Grossniklaus HE; Edelhauser HF; O'Brien JM
Ophthalmology; 2005 Jun; 112(6):1151-8. PubMed ID: 15885791
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the therapeutic effects of lobaplatin and carboplatin on retinoblastoma in vitro and in vivo.
Zhou Z; Jiang H; Xia J; Zhang J
Int J Oncol; 2020 Sep; 57(3):697-706. PubMed ID: 32582992
[TBL] [Abstract][Full Text] [Related]
18. Role of peptidylarginine deiminase 2 (PAD2) in mammary carcinoma cell migration.
Horibata S; Rogers KE; Sadegh D; Anguish LJ; McElwee JL; Shah P; Thompson PR; Coonrod SA
BMC Cancer; 2017 May; 17(1):378. PubMed ID: 28549415
[TBL] [Abstract][Full Text] [Related]
19. Topotecan combination chemotherapy in two new rodent models of retinoblastoma.
Laurie NA; Gray JK; Zhang J; Leggas M; Relling M; Egorin M; Stewart C; Dyer MA
Clin Cancer Res; 2005 Oct; 11(20):7569-78. PubMed ID: 16243833
[TBL] [Abstract][Full Text] [Related]
20. Silencing of lncRNA XIST suppresses proliferation and autophagy and enhances vincristine sensitivity in retinoblastoma cells by sponging miR-204-5p.
Yao L; Yang L; Song H; Liu TG; Yan H
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3526-3537. PubMed ID: 32329826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
